Dr. Charles Griffin Murphy, MD

Dr. Murphy practices at Columbia University Irving Medical Center in New York, New York.

Dr. Murphy's NPI, 1528454725, was assigned on April 14, 2015. Dr. Murphy graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2015. Dr. Murphy holds New York license 294282.

Dr. Murphy's primary practice is Columbia University Irving Medical Center, at 622 W 168th St, New York, NY 10032 in New York County. The practice phone is (212) 297-4255.

Dr. Murphy's primary practice is Columbia University Irving Medical Center in New York, New York. Dr. Murphy is also affiliated with NewYork-Presbyterian/Weill Cornell Medical Center. The medical group on file is Montefiore Einstein Faculty Practice Group. Dmand AI also links Dr. Murphy to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Murphy practices. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Murphy's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Murphy is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Murphy's licenses on file in 2 states: New York and New Jersey.

Dmand AI lists asthma, chronic lung disease, chronic obstructive pulmonary disease (COPD), pleural effusion, pneumonia, pulmonary heart disease and tobacco use among the conditions Dr. Murphy treats.

CMS data shows 779 Medicare services from Dr. Murphy across 13 procedure codes in 2024, for 390 Medicare patients. Medicare paid $55,620 for them.

CMS counts 390 Medicare patients who saw Dr. Murphy in 2024. The largest group is 65 to 74, with 168 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 25% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Murphy's median patient age at 67, with 55% women.

In 2024, Dr. Murphy wrote 1,641 Medicare Part D claims for 241 patients. CMS names the drug for 1,464 of them, across 28 drugs with 11 or more claims each, at $517,558 in total drug cost. In 2023, CMS named 1,380 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Murphy for performance year 2024, reported through an alternative payment model (APM). Dr. Murphy accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Murphy as offering telehealth.

Dmand AI links 6 papers to Dr. Murphy, published from 2019 to 2025. 2025 was the busiest year, with 2. The most frequent topics are Capnography, Dyspnea and Pulmonary Disease, Chronic Obstructive. Dr. Murphy's most frequent co-authors are Charles G. Murphy, MD, Angela M. Dimango, MD and Daniel G. Fein, MD.

CMS Open Payments shows 17 general payments to Dr. Murphy from 7 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $202.

Dr. Murphy graduated from LSU Health Sciences Center New Orleans - School of Medicine in 2015.

Dr. Murphy is in network with 12 carriers, including Aetna, United Healthcare and Elevance. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.